TABLE 1.
Demographic characteristics and laboratory results of COVID‐19 patients on admission
| Non‐pneumonic (n = 154) | Pneumonic (n = 152) | P value | |
|---|---|---|---|
| Age, years | 38.1 ± 13.7 | 39.4 ± 11.5 | .370 |
| Gender, male/female | 76/78 | 71/81 | .644 |
| Comorbidities | |||
| Diabetes mellitus, n (%) | 13 (8.4) | 17 (11.2) | .420 |
| Hypertension, n (%) | 24 (15.6) | 20 (13.2) | .545 |
| Cardiovascular disease, n (%) | 9 (5.8) | 6 (3.9) | .442 |
| Hyperlipidemia, n (%) | 8 (5.2) | 9 (5.9) | .782 |
| Asthma/COPD, n (%) | 7 (4.5) | 10 (6.6) | .437 |
| Laboratory examinations | |||
| WBC, ×103/µL | 5.64 (2.59‐11.56) | 5.48 (2.59‐13.08) | .530 |
| Neutrophil, ×103/µL | 3.05 (0.88‐8.67) | 3.25 (1.48‐8.85) | .081 |
| Lymphocyte, ×103/µL | 1.99 (0.48‐5.05) | 1.63 (0.50‐3.88) | .005 |
| Monocyte, ×103/µL | 0.59 (0.21‐1.50) | 0.48 (0.11‐1.62) | <.001 |
| Eosinophil, ×103/µL | 0.06 (0.0‐1.10) | 0.03 (0.0‐1.60) | <.001 |
| Platelet, ×103/µL | 242 (95‐422) | 230 (84‐590) | .333 |
| Urea, mg/dL | 29.2 ± 9.4 | 29.2 ± 9.2 | .974 |
| Creatinine, mg/dL | 0.88 ± 0.19 | 0.91 ± 0.21 | .330 |
| Prothrombin time, sn | 11.6 (9.6‐16) | 11.5 (10.1‐14.1) | .306 |
| INR | 1.0 (0.84‐1.35) | 1.0 (0.88‐1.17) | .762 |
| D‐dimer, µg/mL | 0.17 (0.15‐3.36) | 0.24 (0.11‐2.66) | .007 |
| CRP, mg/L | 2.03 (0.13‐39.71) | 6.24 (0.60‐202.6) | <.001 |
| Procalcitonin, ng/mL | 0.05 (0.02‐0.16) | 0.05 (0.02‐0.24) | .181 |
| NLR | 1.56 (0.39‐8.79) | 2.03 (0.59‐13.83) | <.001 |
| PLR | 126.9 (36.3‐650) | 145.2 (47.5‐478.2) | .010 |
| MLR | 0.28 (0.11‐1.73) | 0.29 (0.11‐1.13) | .830 |
| ELR | 0.03 (0.0‐0.76) | 0.02 (0.0‐1.09) | .001 |
| CLR | 0.97 (0.05‐21.32) | 4.14 (0.19‐181.18) | <.001 |
Abbreviations: CLR, C‐reactive protein/lymphocyte ratio; CRP, C‐reactive protein; ELR, Eosinophil/lymphocyte ratio; INR, International normalised ratio; MLR, Monocyte/lymphocyte ratio; NLR, Neutrophil/lymphocyte ratio; PLR, Platelet/lymphocyte ratio; WBC, White blood cell count.